Clinical trials
Observational Pancreatic Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2011 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2023 | 2 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
| Completed | 4 |
| Unknown status | 3 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Scientific Corporation | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University | 1 |
| Do Hyun Park | 1 |
| Kaiser Permanente | 1 |
| Mayo Clinic | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Orlando Health, Inc. | 1 |
| Pancreatic Cancer Research Team | 1 |
| Philip Polgreen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Diseases | 18 |
| Pancreatic Neoplasms | 9 |
| Bile Duct Diseases | 4 |
| Pancreatic Cyst | 4 |
| Digestive System Diseases | 3 |
| Gastrointestinal Diseases | 3 |
| Pancreatitis | 3 |
| Colorectal Neoplasms | 2 |
| Gastrointestinal Neoplasms | 2 |
| Pancreatitis, Chronic | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.